These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 20854799

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures.
    Yang D, Peng C, Li X, Fan X, Li L, Ming M, Chen S, Le W.
    J Neurosci Res; 2008 Nov 15; 86(15):3393-400. PubMed ID: 18646205
    [Abstract] [Full Text] [Related]

  • 4. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
    Ostergaard K, Jones SA, Hyman C, Zimmer J.
    Exp Neurol; 1996 Dec 15; 142(2):340-50. PubMed ID: 8934565
    [Abstract] [Full Text] [Related]

  • 5. Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons.
    Du F, Li R, Huang Y, Li X, Le W.
    Eur J Neurosci; 2005 Nov 15; 22(10):2422-30. PubMed ID: 16307585
    [Abstract] [Full Text] [Related]

  • 6. PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease.
    Visanji NP, Orsi A, Johnston TH, Howson PA, Dixon K, Callizot N, Brotchie JM, Rees DD.
    FASEB J; 2008 Jul 15; 22(7):2488-97. PubMed ID: 18364399
    [Abstract] [Full Text] [Related]

  • 7. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
    Otto D, Unsicker K.
    J Neurosci Res; 1993 Mar 01; 34(4):382-93. PubMed ID: 8097265
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
    Moses D, Drago J, Teper Y, Gantois I, Finkelstein DI, Horne MK.
    Neuroscience; 2008 Jun 23; 154(2):606-20. PubMed ID: 18472226
    [Abstract] [Full Text] [Related]

  • 12. Dopaminergic innervation of forebrain by ventral mesencephalon in organotypic slice co-cultures: effects of GDNF.
    Jaumotte JD, Zigmond MJ.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):139-46. PubMed ID: 15790537
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
    Park TH, Mytilineou C.
    Brain Res; 1992 Dec 18; 599(1):83-97. PubMed ID: 1362921
    [Abstract] [Full Text] [Related]

  • 15. Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease.
    Stahl K, Mylonakou MN, Skare Ø, Amiry-Moghaddam M, Torp R.
    Brain Res; 2011 Mar 10; 1378():105-18. PubMed ID: 21236244
    [Abstract] [Full Text] [Related]

  • 16. A non-peptidyl neurotrophic small molecule for midbrain dopaminergic neurons.
    Lin LF, Rubin LL, Xu M.
    J Neurochem; 2004 Jun 10; 89(6):1387-95. PubMed ID: 15189341
    [Abstract] [Full Text] [Related]

  • 17. Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins.
    Nagel F, Bähr M, Dietz GP.
    Brain Res Bull; 2009 Jun 30; 79(5):303-9. PubMed ID: 19406215
    [Abstract] [Full Text] [Related]

  • 18. Qualitative and quantitative re-evaluation of epidermal growth factor-ErbB1 action on developing midbrain dopaminergic neurons in vivo and in vitro: target-derived neurotrophic signaling (Part 1).
    Iwakura Y, Zheng Y, Sibilia M, Abe Y, Piao YS, Yokomaku D, Wang R, Ishizuka Y, Takei N, Nawa H.
    J Neurochem; 2011 Jul 30; 118(1):45-56. PubMed ID: 21517852
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
    Ganser C, Papazoglou A, Just L, Nikkhah G.
    Exp Cell Res; 2010 Mar 10; 316(5):737-46. PubMed ID: 20060824
    [Abstract] [Full Text] [Related]

  • 20. Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro.
    Jin GZ, Cho SJ, Choi EG, Lee YS, Yu XF, Choi KS, Yee ST, Jeon JT, Kim MO, Kong IK.
    Cell Biol Int; 2008 Nov 10; 32(11):1433-8. PubMed ID: 18778785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.